Learn more

IRE CELLTARG SA

Overview
  • Total Patents
    70
About

IRE CELLTARG SA has a total of 70 patent applications. Its first patent ever was published in 1985. It filed its patents most often in France, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD, LANKENAU INST MEDICAL RES and TAIHO PHARMACEUTICAL CO LTD.

Patent filings in countries

World map showing IRE CELLTARG SAs patent filings in countries

Patent filings per year

Chart showing IRE CELLTARG SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Trouet Andre 20
#2 Dejonghe Jean-Paul 9
#3 Collard Marie-Paule 9
#4 Falmagne Jean-Bernard 9
#5 Pirson Philippe 8
#6 Cravador Alfredo 7
#7 Quivy Jacques 7
#8 Bollen Alex 7
#9 Zeicher Marc 6
#10 Baurain Roger 6

Latest patents

Publication Filing date Title
US5244678A Pharmaceutical composition containing a local anesthetic and/or centrally acting analgesic encapsulated in liposomes
EP0362031A1 Compounds active against malaria of the tissues, and process for their preparation
FR2648056A1 Process for the preparation of lipid microparticles of microcrystalline appearance
EP0345153A1 Affinity markers for hormonal steroid receptors, their use in hormonoradio therapy and as imaging agents of hormone-dependent cancers
US5024835A Conjugates of a vinca derivative carrying a detergent chain in the C-3 position
FR2637185A1 LOW MOLECULAR WEIGHT SYNTHETIC VECTORS, USE IN TARGETED THERAPY AND MEDICAL IMAGING AND METHODS OF PREPARATION
FR2635778A1 NEW DERIVATIVES OF 3 (PREMIUM) AZIDO-3 (PRIME) DEOXYTHYMIDINE (AZT) ACTIVE AGAINST AIDS HIV VIRUS
US4897267A Microparticles comprising a biodegradable polymer controlling the release of an antimalaria active principle, pharmaceutical compositions comprising it and process for its preparation
EP0301968A1 Human papilloma virus nucleic acid probes
EP0299878A1 Enzymatic technique using a lyophilised chromogen, kit and method of lyophilisation
FR2631706A1 VIRAL DISEASE DIAGNOSTIC TEST AND METHOD OF FREEZING CELLS USEFUL FOR THIS TEST
WO8807986A2 Compounds useful particularly for radiotherapy or imaging of cancer
EP0286491A1 Antimalarial aminoquinoline derivatives, method for their preparation and pharmaceutical composition containing them
FR2627590A1 NUCLEIC ACID PROBE COMPRISING A CHEMICALLY MODIFIED 5 (PREMIUM) (OH) TERMINAL NUCLEOTIDE FOR NON-RADIOACTIVE MARKING AND METHODS OF PREPARATION
EP0283329A1 Conjugates of a vinca-alkaloid hydrazide bound to an immunoglobulin
EP0236187A1 Imidazole derivatives, preparation processes and pharmaceutical compositions containing them
FR2609399A1 PROCESS FOR INCORPORATING ONE OR MORE LIPOPHILIC ACTIVE INGREDIENTS INTO LIPOPROTEINS, LIPOPROTEINS OBTAINED AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
EP0233101A1 Vinblastine derivatives and pharmaceutical compositions containing them
EP0218488A1 Process for culturing hepatocytes and co-cultures of hepatocytes and of treated liver epithelial cells
EP0208615A1 Antibodies useful as piloting agents, and conjugates containing them